Sleep disturbance | t | df | p-Value (t-test) | |||||
Yes (PSQI > 5) | No (PSQ≦5) | |||||||
Continuous Variables | N | Mean (SD) | N | Mean (SD) | ||||
Age (years) | 392 | 36.4 (7.5) | 122 | 36.2 (7.5) | −0.32 | 512 | 0.751 | |
Education (years) | 392 | 9.9 (2.0) | 122 | 10.0 (1.9) | 0.38 | 512 | 0.704 | |
Life events | 392 | 1.9 (2.2) | 122 | 1.3 (2.0) | −2.60 | 512 | 0.01* | |
Family APGAR score | 392 | 5.9 (4.1) | 122 | 5.3 (4.7) | −1.43 | 512 | 0.156 | |
Criminal convictions (substance) | 392 | 2.5 (1.7) | 122 | 2.2 (1.6) | −1.97 | 512 | 0.05* | |
Criminal convictions (nonsubstance) | 392 | 1.4 (1.6) | 122 | 1.4 (1.4) | −0.31 | 512 | 0.756 | |
Onset age of heroin use (years) | 392 | 25.4 (6.5) | 122 | 26.5 (7.2) | 1.64 | 512 | 0.102 | |
Length of heroin use (years) | 392 | 11.1 (5.7) | 122 | 9.7 (5.7) | −2.24 | 512 | 0.026* | |
Dose of heroin (half qian/day)a | 392 | 6.2 (6.3) | 122 | 7.5 (7.3) | 1.79 | 512 | 0.075 | |
SDS | 392 | 7.5 (2.6) | 122 | 5.5 (2.5) | −7.55 | 512 | <0.001* | |
CAGE | 392 | 1.4 (1.4) | 122 | 1.2 (1.3) | −1.13 | 512 | 0.259 | |
Cigarette consumption | 392 | 1.2 (0.6) | 122 | 1.1 (0.4) | −2.70 | 512 | 0.007* | |
CES-D | 392 | 23.6 (9.3) | 122 | 14.7 (7.8) | −9.59 | 512 | <0.001* | |
QOL-physical health | 392 | 12.4 (1.9) | 122 | 14.2 (2.2) | 8.15 | 512 | <0.001* | |
QOL-psychological | 392 | 11.7 (2.2) | 122 | 13.3 (2.6) | 6.42 | 512 | <0.001* | |
QOL-social relations | 392 | 11.9 (2.3) | 122 | 13.1 (2.4) | 5.13 | 512 | <0.001* | |
QOL-environment | 392 | 11.9 (2.0) | 122 | 13.0 (2.4) | 5.14 | 512 | <0.001* | |
Sleep disturbance | χ2 | df | p-Value (Chi-square) | |||||
Yes (PSQI > 5) | No (PSQ≦5) | |||||||
Categorical Variables | N | % | N | % | ||||
Male | 349 | 89.0% | 113 | 92.6% | 1.32 | 1 | 0.251 | |
Female | 43 | 11.0% | 9 | 7.4% | ||||
Single | 185 | 47.2% | 66 | 54.1% | 3.26 | 2 | 0.196 | |
Married | 84 | 21.4% | 28 | 23.0% | ||||
Divorced, separated, or widowed | 123 | 31.4% | 28 | 23.0% | ||||
Employed | Yes | 219 | 55.9% | 83 | 68.0% | 5.68 | 1 | 0.017* |
No | 173 | 44.1% | 39 | 32.0% | ||||
Injection drug use | Yes | 308 | 78.6% | 79 | 64.8% | 9.55 | 1 | 0.002* |
No | 84 | 21.4% | 43 | 35.2% | ||||
Needle sharing | Yes | 38 | 9.7% | 6 | 4.9% | 2.71 | 1 | 0.100 |
No | 354 | 90.3% | 116 | 95.1% |